John R Petrie

Professor John R Petrie is a Professor of Diabetic Medicine at the University of Glasgow and Director of the Robertson Centre for Biostatistics and Clinical Trials Unit. He holds honorary consultant roles at Glasgow Royal Infirmary and New Stobhill Ambulatory Care Hospital. His research focuses on cardiovascular complications of diabetes, particularly type 1, with a strong emphasis on clinical trials (e.g., the REMOVAL trial) and biomarker discovery. He has led national and international networks like the European Group for the Study of Insulin Resistance and contributed to clinical guidelines for diabetes management. His work spans academic collaborations with global institutions and industry partners.

• Education: MBChB from Edinburgh University (1989), PhD in insulin sensitivity and endothelial function (1997, University of Glasgow).
• Key Roles: Past Reader at the University of Dundee, leader of the Scottish Diabetes Research Network (SDRN), and advisor to multiple journals and grant-awarding bodies (NIH, JDRF, etc.).

Research Interests: Adjunct therapies for type 1 diabetes, metformin’s role beyond type 2 diabetes, and cardiovascular risk mitigation. His studies integrate clinical physiology, pharmacology, and biostatistics, with a focus on translational research and large-scale cohort analysis.

Grants and Trials: Major contributions to the REMOVAL trial (metformin in type 1 diabetes), funded by JDRF. Collaborates with institutions like University College London, Steno Diabetes Center (Denmark), and contract research organizations (e.g., Quintiles, Sanofi). Active in trial design and outcome evaluation for diabetes therapies.